Population pharmacokinetics of boosted saquinavir regimens in HIV-infected individuals

被引:0
|
作者
Dickinson, Laura [1 ]
Boffito, Marta [2 ,3 ]
Back, David [1 ]
Khoo, Saye [1 ]
Pozniak, Anton [2 ,3 ]
Byakika-Kibwika, Pauline [4 ]
Merry, Concepta [4 ]
Autar, Reshma Saskia [5 ]
Burger, David [6 ]
Aarons, Leon [7 ]
机构
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England
[2] PK Res Ltd, St Stephens Ctr, Chelsea, England
[3] Westminster Fdn Trust, London, England
[4] Makerere Univ, Kampala, Uganda
[5] Thai Red Cross Aids Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand
[6] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[7] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester, Lancs, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:995 / 996
页数:2
相关论文
共 50 条
  • [1] Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals
    Dickinson, Laura
    Boffito, Marta
    Back, David J.
    Khoo, Saye H.
    Pozniak, Anton L.
    Mugyenyi, Peter
    Merry, Concepta
    Autar, Reshma Saskia
    Burger, David M.
    Aarons, Leon J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1344 - 1355
  • [2] Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected and healthy individuals
    Dickinson, Laura
    Aarons, Leon
    Back, David
    Khoo, Saye
    Else, Laura
    Waters, Laura
    Pozniak, Anton
    Boffito, Marta
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (02) : 304 - 305
  • [3] Population Pharmacokinetics of Boosted-Elvitegravir in HIV-Infected Patients
    Custodio, Joseph M.
    Gordi, Toufigh
    Zhong, Lijie
    Ling, Kah Hiing J.
    Ramanathan, Srini
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (06): : 723 - 732
  • [4] Population pharmacokinetics (PK) of ritonavir (RTV)-boosted atazanavir (ATV) in HIV-infected and healthy individuals
    Dickinson, L.
    Aarons, L.
    Back, D.
    Waters, L.
    Else, L.
    Khoo, S.
    Pozniak, A.
    Boffito, M.
    [J]. HIV MEDICINE, 2009, 10 : 51 - 52
  • [5] Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients
    Merry, C
    Barry, MG
    Mulcahy, F
    Halifax, KL
    Back, DJ
    [J]. AIDS, 1997, 11 (15) : F117 - F120
  • [6] Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients
    Merry, C
    Barry, MG
    Mulcahy, F
    Ryan, M
    Heavey, J
    Tjia, JF
    Gibbons, SE
    Breckenridge, AM
    Back, DJ
    [J]. AIDS, 1997, 11 (04) : F29 - F33
  • [7] Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjects
    Singh, K.
    Dickinson, L.
    Chaikan, A.
    Back, D.
    Fletcher, C.
    Pozniak, A.
    Moyle, G.
    Nelson, M.
    Gazzard, B.
    Herath, D.
    Boffito, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 867 - 872
  • [8] Ritonavir pharmacokinetics alone and in combination with saquinavir in HIV-infected patients
    Merry, C
    Barry, MG
    Mulcahy, F
    Tjia, JF
    Halifax, KL
    Heavey, J
    Kelly, C
    Back, DJ
    [J]. AIDS, 1998, 12 (03) : 325 - 327
  • [9] Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals
    Smith, PF
    DiCenzo, R
    Forrest, A
    Shelton, M
    Friedland, G
    Para, M
    Pollard, R
    Fischl, M
    DiFrancesco, R
    Morse, GD
    [J]. CLINICAL PHARMACOKINETICS, 2005, 44 (01) : 99 - 109
  • [10] Population Pharmacokinetics of Delavirdine and N-Delavirdine in HIV-Infected Individuals
    Patrick F. Smith
    Robert DiCenzo
    Alan Forrest
    Mark Shelton
    Gerald Friedland
    Michael Para
    Richard Pollard
    Margaret Fischi
    Robin DiFrancesco
    Gene D. Morse
    [J]. Clinical Pharmacokinetics, 2005, 44 : 99 - 109